Stay updated on Nivolumab Ipilimumab in CKS Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in CKS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4. This reflects a new version of the study record published for the page, likely due to minor editorial or QC updates.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release without any change to the trial’s displayed study details.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check77 days agoChange DetectedFooter revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The page content and study details appear unchanged.SummaryDifference0.1%

- Check113 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in CKS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in CKS Clinical Trial page.